Hertz Global Holdings, Inc. (HTZ)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,853	1,122	3,198	5,140	11,832	-
Market Cap Growth	95.70%	-64.90%	-37.77%	-56.56%	-	-
Enterprise Value	21,266	19,597	20,687	18,621	20,694	-
Last Close Price	5.99	3.66	10.39	15.39	24.99	-
PE Ratio	-	-	5.19	2.50	-	-
Forward PE	-	-	10.07	5.85	9.19	-
PS Ratio	0.21	0.12	0.34	0.59	1.61	-
PB Ratio	-	7.34	1.03	1.57	3.98	-
P/OCF Ratio	0.97	0.51	1.29	2.03	6.55	-
EV/Sales Ratio	2.47	2.17	2.21	2.14	2.82	-
EV/EBITDA Ratio	-	-	22.86	8.43	9.30	-
EV/EBIT Ratio	-	-	27.36	9.00	10.20	-
Debt / Equity Ratio	-39.52	120.31	5.77	4.78	4.17	132.75
Debt / EBITDA Ratio	-	-	19.09	7.02	4.13	-
Debt / FCF Ratio	414.92	-	-	-	-	2.28
Asset Turnover	0.36	0.39	0.40	0.41	0.40	0.25
Quick Ratio	0.69	0.44	0.52	1.20	1.89	0.56
Current Ratio	1.26	0.79	0.82	2.06	2.76	1.33
Return on Equity (ROE)	-350.48%	-176.39%	19.34%	65.83%	23.78%	-173.95%
Return on Assets (ROA)	-1.14%	-3.10%	2.01%	6.11%	6.91%	-3.12%
Return on Capital (ROIC)	-1.35%	-3.64%	2.37%	7.53%	9.11%	-3.89%
Return on Capital Employed (ROCE)	-	-	3.60%	10.00%	11.20%	-
Earnings Yield	-137.52%	-254.97%	19.26%	40.06%	3.09%	-
FCF Yield	2.59%	-64.77%	-54.09%	-33.27%	-21.98%	-
Payout Ratio	-	-	-	-	65.30%	-
Buyback Yield / Dilution	-	6.13%	19.11%	-27.94%	-110.00%	-28.21%

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q